Turkey is a key emerging market for pharmaceutical companies with a well-organised pharmaceutical industry. Harmonisation with EU rules has facilitated access for new medicines, and Turkey has grown into an important market for the international pharmaceutical industry.
The government aims to make Turkey one of the world’s top 10 economies in the field of health services by 2023. As a result, Turkey’s pharmaceutical industry is expected to reach $23 billion turnover by 2023 and imported products will continue to account for approximately half of the market share (Turkey’s Pharmaceutical Sector – Vision 23 Report Strategy Document).
MAP Tag Cloud
Use the word cloud below to search for common topics – the larger the font, the more frequently it occurs.